Sarah Fayad

CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer’s disease PSEN1 M146L mutation

Martin J. Aryee, J. Joung, V. Pattanayak, 2022, Molecular therapy. Nucleic acids.